Oracle, the leading business software and hardware systems company, has launched the latest version of its centralized solution for integrating, managing and analyzing clinical trial information.

Oracle Health Sciences Clinical Development Center 3.1 provides new integration, increased automation, and expanded data standardization to enable accelerated processing of clinical trial data from multiple sources in a variety of formats and increased user productivity from capture through submission, a statement said.

The new release features automated data load and new execution triggers to increase the timeliness and accuracy of data analysis.

The system now automatically reruns routines and programs against the most recent data and notifies users of data and study changes as they occur. The system can also be personalized to notify users of specific events that require their attention.

Newly enhanced governance capabilities allow for the creation of validated libraries to drive standardization, control and reuse of data models, macros, and programs across studies.

These features help increase the quality, consistency and reliability of data delivery, while accelerating study set up time and decreasing validation efforts required for each study, the statement said.

Version 3.1 also features a pre-built integration with Oracle Health Sciences InForm GTM electronic data capture (EDC) solution, as well as enhanced support for Medidata Rave clinical data management and EDC platform, automating the set up of Medidata Rave studies and data loading to save time and reduce potential for error.

Oracle Health Sciences Clinical Development Center 3.1 now also supports the use of Interactive SAS for program development, and integrates with Oracle’s Siebel Clinical Trial Management System to help auto load study metadata, according to the statement.

To accommodate the increasingly global nature of the clinical trial process, the latest version also supports the management of data from studies in multiple languages.

“As clinical trials continue to expand in scope, complexity, and cost, trial sponsors and contract research organizations require solutions that enable them to efficiently aggregate and process rapidly growing volumes of clinical trial data emanating from multiple sources,” said Neil de Crescenzo, senior vice president and general manager, Oracle Health Sciences.

“The Oracle Clinical Development Center 3.1, via its new integration capabilities and standardization enhancements, enables organizations to further accelerate data aggregation and reconciliation, streamline preparation for analysis, automate the downstream analysis process, and ensure control and compliance,” he added. – TradeArabia News Service